TMEM239
gene geneOn this page
Summary
TMEM239 (transmembrane protein 239, HGNC:40044) is a protein-coding gene on chromosome 20p13, encoding Transmembrane protein 239 (Q8WW34).
Predicted to be located in membrane.
Source: NCBI Gene 100288797 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 29 total
- MANE Select transcript:
NM_001167670
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:40044 |
| Approved symbol | TMEM239 |
| Name | transmembrane protein 239 |
| Location | 20p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000198326 |
| Ensembl biotype | protein_coding |
| Entrez | 100288797 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000361033, ENST00000380585
RefSeq mRNA: 2 — MANE Select: NM_001167670
NM_001167670, NM_001318207
CCDS: CCDS54444, CCDS82595
Canonical transcript exons
ENST00000380585 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001485547 | 2816544 | 2818062 |
| ENSE00001485548 | 2816364 | 2816415 |
Expression profiles
Bgee: expression breadth broad, 29 present calls, max score 89.89.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0711 / max 66.7606, expressed in 3 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 183186 | 0.0556 | 3 |
| 183185 | 0.0089 | 3 |
| 208974 | 0.0066 | 3 |
Top tissues by expression
218 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 89.89 | gold quality |
| left testis | UBERON:0004533 | 89.88 | gold quality |
| testis | UBERON:0000473 | 85.51 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 71.66 | gold quality |
| adult organism | UBERON:0007023 | 66.42 | gold quality |
| sperm | CL:0000019 | 56.87 | gold quality |
| cartilage tissue | UBERON:0002418 | 54.50 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 53.09 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 52.70 | gold quality |
| decidua | UBERON:0002450 | 51.43 | silver quality |
| trabecular bone tissue | UBERON:0002483 | 50.47 | gold quality |
| lower lobe of lung | UBERON:0008949 | 49.97 | silver quality |
| substantia nigra pars reticulata | UBERON:0001966 | 49.96 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 48.40 | gold quality |
| skin of hip | UBERON:0001554 | 46.32 | silver quality |
| biceps brachii | UBERON:0001507 | 46.19 | gold quality |
| sural nerve | UBERON:0015488 | 45.70 | gold quality |
| saphenous vein | UBERON:0007318 | 45.61 | gold quality |
| bone marrow | UBERON:0002371 | 45.26 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 45.07 | gold quality |
| deltoid | UBERON:0001476 | 43.60 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| placenta | UBERON:0001987 | 43.35 | gold quality |
| vastus lateralis | UBERON:0001379 | 43.26 | gold quality |
| quadriceps femoris | UBERON:0001377 | 43.17 | gold quality |
| amniotic fluid | UBERON:0000173 | 42.87 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 42.64 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| heart right ventricle | UBERON:0002080 | 42.39 | gold quality |
| bone marrow cell | CL:0002092 | 42.21 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 32.83 |
| E-ANND-3 | no | 1.47 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
30 targeting TMEM239, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-1283 | 99.69 | 72.42 | 3009 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-587 | 99.64 | 70.86 | 2611 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-5693 | 99.24 | 66.67 | 1106 |
| HSA-MIR-6815-3P | 99.13 | 68.98 | 1530 |
| HSA-MIR-4795-5P | 99.11 | 66.90 | 876 |
| HSA-MIR-421 | 98.90 | 67.04 | 1883 |
| HSA-MIR-6829-5P | 98.86 | 65.12 | 1480 |
| HSA-MIR-3922-5P | 98.77 | 66.53 | 1059 |
| HSA-MIR-7113-3P | 98.75 | 65.71 | 1120 |
| HSA-MIR-4709-5P | 98.51 | 67.25 | 1335 |
| HSA-MIR-5089-5P | 98.45 | 66.06 | 1388 |
| HSA-MIR-3670 | 97.88 | 64.39 | 763 |
| HSA-MIR-2467-5P | 97.36 | 67.71 | 991 |
| HSA-MIR-194-3P | 97.36 | 65.96 | 1027 |
| HSA-MIR-6895-5P | 97.05 | 64.96 | 522 |
| HSA-MIR-6759-3P | 96.94 | 68.31 | 823 |
| HSA-MIR-3189-3P | 96.80 | 66.34 | 896 |
| HSA-MIR-597-3P | 96.46 | 68.03 | 1035 |
| HSA-MIR-2909 | 96.36 | 67.30 | 562 |
| HSA-MIR-1266-3P | 96.23 | 66.36 | 778 |
| HSA-MIR-3174 | 94.63 | 63.64 | 577 |
| HSA-MIR-1296-5P | 93.94 | 67.71 | 305 |
| HSA-MIR-4787-3P | 89.45 | 70.48 | 40 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tmem239 | ENSMUSG00000049692 |
| rattus_norvegicus | Tmem239 | ENSRNOG00000047004 |
Protein
Protein identifiers
Transmembrane protein 239 — Q8WW34 (reviewed: Q8WW34)
All UniProt accessions (1): Q8WW34
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8WW34-1 | 1 | yes |
| Q8WW34-2 | 2 |
RefSeq proteins (2): NP_001161142, NP_001305136 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031694 | TMEM239 | Family |
Pfam: PF15841
UniProt features (4 total): transmembrane region 2, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WW34-F1 | 73.01 | 0.34 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 36 (showing top):
ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, MIR616_5P, MIR371B_5P, MIR373_5P, GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN, MIR4719, MIR7106_5P, MIR6780A_5P, MIR1273H_5P, MIR6815_3P, MIR6779_5P, MIR30B_3P, MIR3689A_3P_MIR3689B_3P_MIR3689C, MIR1913, MIR6837_5P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
96 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM239 | BPIFC | Q8NFQ6 | 591 |
| TMEM239 | AIRIM | Q9NX04 | 580 |
| TMEM239 | MORN2 | Q502X0 | 506 |
| TMEM239 | AKIRIN1 | Q9H9L7 | 485 |
| TMEM239 | ADCK1 | Q86TW2 | 474 |
| TMEM239 | MRPS31 | Q92665 | 433 |
| TMEM239 | ZDBF2 | Q9HCK1 | 398 |
| TMEM239 | STYK1 | Q6J9G0 | 392 |
| TMEM239 | TSPAN13 | O95857 | 371 |
| TMEM239 | STMN3 | Q9NZ72 | 360 |
| TMEM239 | DMTN | Q08495 | 355 |
| TMEM239 | FHIP2B | Q86V87 | 340 |
| TMEM239 | ST6GAL1 | P15907 | 337 |
| TMEM239 | FBXL2 | Q9UKC9 | 325 |
| TMEM239 | BUB3 | O43684 | 312 |
IntAct
38 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM239 | SDCBP | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM239 | ATF7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| USP5 | TMEM239 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FGD2 | TMEM239 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYG1 | TMEM239 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM239 | COQ8A | psi-mi:“MI:0915”(physical association) | 0.560 |
| CXCL16 | TMEM239 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM239 | LENG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM239 | NTAQ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM239 | SENP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POLI | TMEM239 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ATF7 | TMEM239 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM239 | USP5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM239 | FGD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| COQ8A | TMEM239 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM239 | CXCL16 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NTAQ1 | TMEM239 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SENP2 | TMEM239 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM239 | MYG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (77): TMEM239 (Two-hybrid), TMEM239 (Two-hybrid), TMEM239 (Two-hybrid), TMEM239 (Two-hybrid), TMEM239 (Two-hybrid), TMEM239 (Two-hybrid), TMEM239 (Two-hybrid), TMEM239 (Two-hybrid), TMEM239 (Two-hybrid), TMEM239 (Two-hybrid), TMEM239 (Two-hybrid), TMEM239 (Two-hybrid), TMEM239 (Two-hybrid), TMEM239 (Two-hybrid), TMEM239 (Two-hybrid)
ESM2 similar proteins: A0A096P2H6, A0A0D9S1R4, A0A2Y9GDB5, A0JNN2, A8MXV6, D2H5P6, E1BLZ4, E1C7U0, P0DKW1, P0DKW2, P0DKW3, P0DKW4, P0DKY3, P0DML4, P0DML5, P0DML6, P0DMN8, P0DOC4, P0DP53, P0DTG9, P0DTH0, P0DTH1, P0DTH2, P0DTH3, P0DTH4, P0DUP6, P24001, P55056, P55797, Q2TBQ4, Q32KP7, Q3SYR5, Q5EAA5, Q5JX69, Q5R7E2, Q5U2R2, Q68DK2, Q6MG51, Q6P0A1, Q6UJB9
Diamond homologs: Q8WW34, Q9DA47
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
29 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
292 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:2816413:GAG:G | donor_gain | 1.0000 |
| 20:2816385:G:GT | donor_gain | 0.9900 |
| 20:2816414:AGGTA:A | donor_loss | 0.9900 |
| 20:2816416:G:GG | donor_gain | 0.9800 |
| 20:2816412:AGAG:A | donor_gain | 0.9200 |
| 20:2816413:GAGG:G | donor_gain | 0.9200 |
| 20:2816538:CCCCA:C | acceptor_loss | 0.9100 |
| 20:2816540:CCA:C | acceptor_loss | 0.9100 |
| 20:2816541:CA:C | acceptor_loss | 0.9100 |
| 20:2816806:T:A | acceptor_gain | 0.9000 |
| 20:2816411:CAGAG:C | donor_gain | 0.8900 |
| 20:2816414:AG:A | donor_gain | 0.8800 |
| 20:2816415:GG:G | donor_gain | 0.8800 |
| 20:2816804:ACT:A | acceptor_gain | 0.8700 |
| 20:2816542:A:AG | acceptor_gain | 0.8400 |
| 20:2816543:G:GG | acceptor_gain | 0.8400 |
| 20:2816543:GGT:G | acceptor_gain | 0.8000 |
| 20:2816418:AA:A | donor_loss | 0.7900 |
| 20:2816916:C:CA | acceptor_gain | 0.7200 |
| 20:2816999:G:GT | donor_gain | 0.7000 |
| 20:2816804:ACTG:A | acceptor_gain | 0.6900 |
| 20:2816503:CAAGG:C | acceptor_gain | 0.6600 |
| 20:2816504:AAGG:A | acceptor_gain | 0.6600 |
| 20:2816804:A:AG | acceptor_gain | 0.6600 |
| 20:2816503:CAAG:C | acceptor_loss | 0.6400 |
| 20:2816505:A:AT | acceptor_loss | 0.6400 |
| 20:2816505:A:G | acceptor_gain | 0.6400 |
| 20:2816506:GGTC:G | acceptor_loss | 0.6400 |
| 20:2816490:T:TA | acceptor_loss | 0.6300 |
| 20:2816807:G:A | acceptor_gain | 0.6300 |
AlphaMissense
963 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:2816951:A:C | S176R | 0.986 |
| 20:2816953:C:A | S176R | 0.986 |
| 20:2816953:C:G | S176R | 0.986 |
| 20:2816891:A:C | S156R | 0.985 |
| 20:2816893:T:A | S156R | 0.985 |
| 20:2816893:T:G | S156R | 0.985 |
| 20:2816798:T:C | F125L | 0.956 |
| 20:2816800:C:A | F125L | 0.956 |
| 20:2816800:C:G | F125L | 0.956 |
| 20:2816786:T:C | C121R | 0.950 |
| 20:2816807:G:C | G128R | 0.930 |
| 20:2816901:C:G | P159R | 0.925 |
| 20:2816924:T:C | F167L | 0.919 |
| 20:2816926:C:A | F167L | 0.919 |
| 20:2816926:C:G | F167L | 0.919 |
| 20:2816751:A:T | E109V | 0.907 |
| 20:2816852:T:A | W143R | 0.904 |
| 20:2816852:T:C | W143R | 0.904 |
| 20:2816817:T:C | L131P | 0.896 |
| 20:2816901:C:A | P159H | 0.893 |
| 20:2816799:T:C | F125S | 0.891 |
| 20:2816912:T:C | F163L | 0.891 |
| 20:2816914:C:A | F163L | 0.891 |
| 20:2816914:C:G | F163L | 0.891 |
| 20:2816808:G:A | G128D | 0.890 |
| 20:2816796:T:A | L124H | 0.887 |
| 20:2816943:C:A | T173K | 0.885 |
| 20:2816752:G:C | E109D | 0.871 |
| 20:2816752:G:T | E109D | 0.871 |
| 20:2816895:C:A | A157D | 0.871 |
dbSNP variants (sampled 300 via entrez): RS1000129781 (20:2820214 G>A,C), RS1001669108 (20:2816656 G>A), RS1003213980 (20:2819405 A>C), RS1003233463 (20:2813958 A>C,G), RS1003677307 (20:2819072 C>T), RS1004826457 (20:2816131 G>A), RS1004940719 (20:2816330 G>A,C), RS1005492682 (20:2818699 C>T), RS1005602385 (20:2819119 T>C), RS1005824594 (20:2817235 A>G), RS1005940692 (20:2817489 C>A,G), RS1006607948 (20:2820548 C>T), RS1006714837 (20:2814591 C>A), RS1007120285 (20:2817485 G>A,C), RS1007238752 (20:2814900 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001760_7 | White matter integrity | 7.000000e-06 |
| GCST006626_34 | Pulse pressure | 5.000000e-11 |
| GCST008747_138 | Estimated glomerular filtration rate | 2.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004641 | white matter integrity |
| EFO:0005763 | pulse pressure measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation | 1 |
| Valproic Acid | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.